VCNX News and Press, Vaccinex Inc. From 04/21/21

Vaccinex (VCNX) announces results from the its CLASSICAL-Lung clinical trial in the journal Clinical Cancer Research.The Phase 1b/2 trial evaluated pepinemab, in combination with the immune checkpoint inhibitor Bavencio (avelumab) for the treatment of non-small cell lung cancer ((NSCLC))...

ROCHESTER, N.Y., April 21, 2021 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company pioneering a differentiated approach to treating cancer and neurodegenerative disease through the inhibition of SEMA4D, today announced the publication of results from t...

Vaccinex (VCNX): FY Revenue of $0.63M (+21.2% Y/Y) beats by $0.02M.Cash and cash equivalents and marketable securities of $10.6MShares +8.15% PM.Press Release For further details see: Vaccinex beats on revenue

Reported top-line results from Phase 2 SIGNAL study that indicates potential cognitive benefit of pepinemab in neurodegenerative disease. New Alzheimer’s study expected to begin enrollment in Q2 Phase 1/2 study to evaluate pepinemab in combination with KEYTRUDA® in a...

Entera Bio Ltd. (ENTX +51% following osteoporosis drug results.ContraFect Corporation (CFRX +35% on receiving $86.8M in BARDA contract.GigaMedia Limited (GIGM) +34%.Seelos Therapeutics (SEEL +30% as BTIG initiates with street high target.Fujian Blue Hat Interacti...

ROCHESTER, N.Y., March 11, 2021 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company pioneering a differentiated approach to treating cancer and neurodegenerative disease through the inhibition of SEMA4D, today announced that Dr. Maurice Zauderer, chief ...

Today, we take our first in-depth look at small cap developmental firm Vaccinex since April of last year. The company has signed a couple of interesting deals over the past weeks that merited a reassessment. An updated investment thesis on Vaccinex follows below. For further...

IT Tech Packaging (ITP) -23% on stock offering.Ping Identity Holding (PING) -14% on Q4 results.ReTo Eco-Solutions (RETO) -10%.United States Antimony (UAMY) -9%.BioCryst Pharmaceuticals (BCRX) -9% on Q4 earnings.Best Buy (BBY) -7% on Q4 results.Chimerix (CMRX) -7% on Q...

4 Biotech Penny Stocks to Watch Right Now Over the past twelve months, interest in biotech penny stocks has continued to see new peaks. While this is partly due to the pandemic’s effects, it seems that it goes beyond this. Due to Covid, a massive influx of capital has come in...

Gainers: Vascular Biogenics (VBLT) +22%, Sunesis Pharmaceuticals (SNSS) +21%, Savara (SVRA) +8%, Pandion Therapeutics (PAND) +5%.Losers: PAVmed (PAVM) -17%, Isoray (ISR) -16%, Vaccinex (VCNX) -16%, Onconova Therapeutics (ONTX) -15%, elect...